Efficient reduction of PD‐L1 expression could be achieved by inhibiting FOXM1 protein via siRNA‐mediated knockdown or TST treatment under conditions that mimic malignant tumors (Figures 3, 4, and 5). The gene discussed is FOXM1; the disease is cancer.